The Business Brew cover image

Ian Cassel - A Micro Perspective

The Business Brew

00:00

The Importance of Drugs in the Alzheimer's Space

Alzheimer's would probably be 70% of their core business, but that's mainly because of some of these late state Alzheimer's assets being in phase three trials. These are big opportunities, you know, drugs that could do 15 20 billion a year. When Eli Lilly announces anything positive about this one drug, it can move that stock 10%. Yeah.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app